tiprankstipranks
Advertisement
Advertisement
Rallybio to Merge with Candid Therapeutics in All-Stock Deal
PremiumCompany AnnouncementsRallybio to Merge with Candid Therapeutics in All-Stock Deal
3M ago
Rallybio, Candid Therapeutics announce merger agreement
Premium
The Fly
Rallybio, Candid Therapeutics announce merger agreement
3M ago
Rallybio’s RLYB116 Clears Phase 1 Milestone, Sharpening Its Autoimmune Pipeline
Premium
Company Announcements
Rallybio’s RLYB116 Clears Phase 1 Milestone, Sharpening Its Autoimmune Pipeline
3M ago
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/10/26
PremiumMarket NewsVanguard Total Stock Market ETF (VTI) Daily Snapshot—2/10/26
3M ago
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/9/26
Premium
Market News
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/9/26
4M ago
Rallybio Corp trading halted, news pending
Premium
The Fly
Rallybio Corp trading halted, news pending
4M ago
Rallybio’s Phase 2 FNAIT Prevention Study Reaches Completion: What Investors Should Watch Next
PremiumCompany AnnouncementsRallybio’s Phase 2 FNAIT Prevention Study Reaches Completion: What Investors Should Watch Next
5M ago
Rallybio Corporation Reports Strong Q3 2025 Results
Premium
Company Announcements
Rallybio Corporation Reports Strong Q3 2025 Results
7M ago
Rallybio’s RLYB116 Study: A Potential Game-Changer in Hematologic and Autoimmune Disease Treatment
Premium
Company Announcements
Rallybio’s RLYB116 Study: A Potential Game-Changer in Hematologic and Autoimmune Disease Treatment
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100